Dr. Susannah Catherine Cooper, MD

Dr. Cooper practices at Centra Specialty Hospital in Lynchburg, Virginia, part of Centra Health.

Dr. Cooper's NPI, 1790846038, was assigned on December 12, 2006. Dr. Cooper holds Arizona license 62128.

Dr. Cooper's primary practice is Centra Specialty Hospital, at 3300 Rivermont Avenue, Krise Building, 5th Floor, Lynchburg, VA 24503 in Lynchburg City. The practice phone is (434) 200-1960.

Dr. Cooper's primary practice is Centra Specialty Hospital in Lynchburg, Virginia, part of Centra Health. Dr. Cooper is also affiliated with Centra Lynchburg General Hospital. The medical group on file is Centra Medical Group. Dmand AI also links Dr. Cooper to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cooper practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Cooper's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Cooper's licenses on file in 4 states: Arizona, Tennessee, Texas and Virginia.

CMS data shows 15,335 Medicare services from Dr. Cooper across 32 procedure codes in 2024, for 489 Medicare patients. Medicare paid $271,900 for them.

CMS counts 489 Medicare patients who saw Dr. Cooper in 2024. The largest group is 75 to 84, with 228 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cooper's median patient age at 75, with 63% women.

In 2024, Dr. Cooper wrote 1,172 Medicare Part D claims for 323 patients. 88% of them were for generic drugs. CMS names the drug for 891 of them, across 20 drugs with 11 or more claims each, at $878,630 in total drug cost. In 2023, CMS named 974 claims across 26 drugs.

Dr. Cooper accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cooper as offering telehealth.

Dmand AI links 1 paper to Dr. Cooper in 2016. Dr. Cooper's most frequent co-authors are Alexander W. Brown, MD and Robert Frank Setlik, MD, PhD.

Dmand AI links Dr. Cooper to 10 clinical trials, 9 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic. Alliance for Clinical Trials in Oncology sponsors the most, 3.

CMS Open Payments shows 290 general payments to Dr. Cooper from 53 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 89% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,196.